Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Return on Sales: 2023-2025

Historic Return on Sales for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to 135.42%.

  • Mereo BioPharma Group's Return on Sales was N/A to 135.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 135.42%, marking a year-over-year change of. This contributed to the annual value of 31.57% for FY2024, which is 3452.00% up from last year.
  • According to the latest figures from Q3 2025, Mereo BioPharma Group's Return on Sales is 135.42%, which was up 154.71% from 53.17% recorded in Q2 2025.
  • Mereo BioPharma Group's 5-year Return on Sales high stood at 135.42% for Q3 2025, and its period low was -3.47% during Q4 2023.
  • Its 3-year average for Return on Sales is 51.42%, with a median of 38.09% in 2025.
  • Examining YoY changes over the last 5 years, Mereo BioPharma Group's Return on Sales showed a top increase of 4,102bps in 2025 and a maximum decrease of 5,489bps in 2025.
  • Mereo BioPharma Group's Return on Sales (Quarterly) stood at -3.47% in 2023, then skyrocketed by 3,506bps to 31.59% in 2024, then slumped by 5,489bps to 135.42% in 2025.
  • Its last three reported values are 135.42% in Q3 2025, 53.17% for Q2 2025, and 38.09% during Q1 2025.